| Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase {beta} in their mammary glands (2006) | |||||||||||||
Abstract | |||||||||||||
| DNA polymerase β (polβ) is a major contributor to mammalian DNA damage repair through its gap-filling DNA synthesis and 5/-deoxyribose phosphate lyase activities. In this way, polβ plays pivotal roles in the repair of oxidative DNA damage, replication, embryonic survival, neuronal development, meiosis, apoptosis and telomere function. A 36-kDa truncated polβΔ protein is expressed in human colorectal, breast, lung and renal carcinomas, but not in normal matched tissues. Interestingly, a binary protein-protein complex of polβΔ and XRCC1 acts as dominant-negative mutant. In this study, the potential tumorigenic activity of polβΔ was examined in nude and transgenic mouse models. Mouse embryonic fibroblasts expressing polβΔ in the absence of endogenous polβ exhibited increased susceptibility to N-methyl-N-nitrosourea (MNU)-induced morphological transformation as compared to cells expressing wild-type polβ. This was accompanied by reduced gap-filling DNA synthesis activity. Anchorage-independent transformed cells derived from polβΔ-expressing MEFs induced 100% tumor occurrence in nude mice. To support these data, we established transgenic mice expressing polβΔ specifically in the mammary glands from a whey acidic protein (WAP) promoter-driven-transgene. This is the first report of transgenic mice with tissue-specific expression of polβΔ. MNU-induced tumor formation was analyzed in transgenic mice expressing polβΔ together with endogenous wild-type polβ in their mammary glands and in normal control mice expressing only wild-type polβ. The latent period of tumor appearance was markedly shorter and tumor incidence was significantly higher in transgenic animals than in control animals treated under the same conditions. These results indicate that cells expressing the mutant polβΔ display an enhanced sensitivity to MNU that likely underlies an increased susceptibility to tumorigenesis. | |||||||||||||
Publication details | |||||||||||||
| |||||||||||||